Lv2
146 积分 2025-07-28 加入
The recent advance of PROTACs targeting BCR-ABL for the treatment of chronic myeloid leukemia
11小时前
已完结
Global PROTAC Toolbox for Degrading BCR–ABL Overcomes Drug-Resistant Mutants and Adverse Effects
13小时前
已完结
Drug repurposing and structure-based discovery of new PDE4 and PDE5 inhibitors
1天前
已完结
Toward Automated Physics-Based Absolute Drug Residence Time Predictions
8天前
已完结
The allosteric inhibitor ABL001 enables dual targeting of BCR–ABL1
1个月前
已完结
Revealing Atropisomer Axial Chirality in Drug Discovery
1个月前
已完结
Subtle changes in ligand-receptor interactions dramatically alter transcriptional outcomes of pregnane X receptor modulators
1个月前
已完结
Structure of gut microbial glycolipid modulates host inflammatory response
2个月前
已完结
Induced proximity at the cell surface
3个月前
已完结
Enzyme-Activated Sugar-Coated Bifunctional Degraders
3个月前
已完结
皖公网安备34019202002308
